A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetes Mellitus Type 2

In brief

The purpose of this study is to assess the potential of BMS-986036 for treatment obese adults with type-2 diabetes.

Key facts

Study ID
NCT02097277
Run by
Bristol-Myers Squibb
People needed
219
Starts
2014-04-15
Expected to finish
2016-05-17
Last updated by the study team
2019-07-31

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.